105,026 research outputs found

    Teede, W H, 16774

    No full text
    This record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete. Visit this record in UMA's new catalogue at: https://archives.library.unimelb.edu.au/nodes/view/420818Surname: TEEDE. Given Name(s) or Initials: W H. Military Service Number or Last Known Location: 16774. Missing, Wounded and Prisoner of War Enquiry Card Index Number: 50089.245528 Item: [2016.0049.53079] "Teede, W H, 16774

    Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society

    No full text
    Copyright © 2009 American Society for Reproductive Medicine Published by Elsevier Inc.ObjectiveTo summarize current evidence on lifestyle management (dietary, exercise, or behavioral interventions) of obesity in women with polycystic ovary syndrome (PCOS), to indicate gaps in knowledge, and to review the medical and surgical alternatives for weight management.DesignExpert panel appointed by the Androgen Excess and PCOS Society (AEPCOS Society) to review the literature and draft the initial report after a consensus process via electronic communication. The initial report was reviewed and critiqued by all expert panel members and the AEPCOS Society Board of Directors and modified based on their comments.Conclusion(s)Lifestyle management should be used as the primary therapy in overweight and obese women with PCOS for the treatment of metabolic complications. For reproductive abnormalities, lifestyle modification may improve ovulatory function and pregnancy. Data are preliminary for improvement in pregnancy and live-birth rates, and further research is needed. There is currently no evidence that modifying dietary macronutrient composition offers additional benefits over conventional dietary approaches for weight loss, and further research is needed. Emerging evidence suggests that exercise offers additional benefits to dietary energy restriction for reproductive features of PCOS.Lisa J. Moran, Renato Pasquali, Helena J. Teede, Kathleen M. Hoeger and Robert J. Norma

    Cardiometabolic risks in polycystic ovary syndrome: non-traditional risk factors and the impact of obesity

    No full text
    Abstract not availableWei-Ling Chiu, Jacqueline Boyle, Amanda Vincent, Helena Teede, Lisa J. Mora

    Polycystic ovary syndrome: what do the new guidelines recommend?

    No full text
    Polycystic ovary syndrome (PCOS) is a prevalent, chronic, heterogeneous condition with reproductive, metabolic and psychological features. Treatment focuses on relieving symptoms and preventing future complications with a strong emphasis on lifestyle intervention, augmented with targeted medical therapy. New national evidence-based guidelines are now available to help clinicians assess and manage women with PCOS. © Dr Najeeb Layyous/Science Photo Library.Anju E Joham, Helena J Teede, Robert J Normanhttp://www.medicinetoday.com.au/2012/may/article/polycystic-ovary-syndrome-what-do-new-guidelines-recommend-0#.UurbIFP84X

    Polycystic ovarian syndrome - Insights into the enigma that is PCOS today

    No full text
    The original publication can be found at www.springerlink.comPolycystic ovary syndrome (PCOS) is an endocrine condition with both reproductive and metabolic implications. It affects 6–10% of reproductive aged women making it the most common endocrinopathy in this group of women. It is a frequent cause of infertility, has potential for serious long-term complications, and represents a major cost burden on the health care system. Although PCOS is a heterogeneous condition and many research challenges remain, it is imperative that clinicians are aware of the recent advances in the area. This special section reviews the current literature on PCOS including controversies in diagnostic criteria, etiology, metabolic and cardiovascular implications, and the debate over ideal therapies focusing on lifestyle modification, insulin sensitisers, and infertility therapyH.J. Teede and R. Norma

    Going Beyond Counting First Authors in Author Co-citation Analysis

    No full text
    The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed

    Appropriate Similarity Measures for Author Cocitation Analysis

    No full text
    We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis

    Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome

    No full text
    Abstract not availableL.J. Moran, H.J. Teede, M. Noakes, P.M. Clifton, R.J. Norman and G.A. Witterthttp://www.jendocrinolinvest.it/jei/en/abstract.cfm?articolo_id=902

    Vitamin D is independently associated with depression in overweight women with and without PCOS

    No full text
    Background: Depression, anxiety, and inflammation are common in polycystic ovary syndrome (PCOS). Inflammation may adversely impact on mood and vitamin D has been associated with both mood disorders and inflammation in the general population, but these relationships have not been studied in PCOS. The aim of this study was to investigate the association among 25 hydroxy-Vitamin D (25OHVD) status, anxiety, depression, and inflammation in women with and without PCOS. Methods: Cross-sectional study in overweight or obese premenopausal women with (n = 50) and without (n = 23) PCOS. Primary outcome measures were 25OHVD, mood (Hospital Anxiety and Depression questionnaire), and inflammation (highly sensitive C-reactive protein (hsCRP)). Results: Vitamin D deficiency (25OHVD<50 nmol/L) (46% versus 39%, p = 0.311) and 25OHVD (50.4 ± 22.2 nmol/L versus 51.6 ± 19.0 nmol/L, p = 0.828) were not significantly different in women with and without PCOS. For all women combined, 25OHVD was the only significant independent predictor of depression (β = −0.063 ± 0.021, p = 0.005) and hsCRP (β = −0.041 ± 0.015, p = 0.010). Conclusions: Vitamin D deficiency is common in both women with and without PCOS with no differences between the groups. Vitamin D is independently associated with depression and inflammation in overweight women both with and without PCOS. Further investigation to clarify the interrelationship among vitamin D, inflammation and depression is required to identify optimal prevention and treatment strategies for psychological and metabolic dysfunction in PCOS.L. J. Moran, H. J. Teede & A. J. Vincen

    Dispelling the Myths Behind First-author Citation Counts

    No full text
    We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more sophisticated methods
    corecore